TWISTNB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.891800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.222600E-01
Normal-vs-Stage2
7.996200E-01
Normal-vs-Stage3
1.572170E-01
Normal-vs-Stage4
7.684100E-02
Stage1-vs-Stage2
9.160000E-01
Stage1-vs-Stage3
1.274370E-01
Stage1-vs-Stage4
9.477600E-03
Stage2-vs-Stage3
1.428760E-01
Stage2-vs-Stage4
4.783200E-03
Stage3-vs-Stage4
2.720300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.691800E-01
Normal-vs-AfricanAmerican
9.131400E-01
Normal-vs-Asian
5.770400E-01
Caucasian-vs-AfricanAmerican
5.558600E-01
Caucasian-vs-Asian
4.564200E-01
AfricanAmerican-vs-Asian
3.894400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.887000E-01
Normal-vs-Female
8.106600E-01
Male-vs-Female
7.907200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.584800E-01
Normal-vs-Age(41-60Yrs)
8.287800E-01
Normal-vs-Age(61-80Yrs)
6.171200E-01
Normal-vs-Age(81-100Yrs)
6.672200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.989800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.430600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.873400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.189720E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.446600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.706800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.432400E-01
Normal-vs-Daily Drinker
3.984000E-01
Normal-vs-Weekly Drinker
9.800200E-01
Normal-vs-Occasional Drinker
7.110800E-01
Normal-vs-Social Drinker
9.963800E-01
Non Drinker-vs-Daily Drinker
7.055000E-01
Non Drinker-vs-Weekly Drinker
1.374180E-01
Non Drinker-vs-Occasional Drinker
1.722480E-02
Non Drinker-vs-Social Drinker
4.792100E-02
Daily Drinker-vs-Weekly Drinker
1.836780E-01
Daily Drinker-vs-Occasional Drinker
3.234400E-02
Daily Drinker-vs-Social Drinker
1.473200E-01
Weekly Drinker-vs-Occasional Drinker
5.576400E-01
Weekly Drinker-vs-Social Drinker
9.576400E-01
Occasional Drinker-vs-Social Drinker
4.771000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.276400E-01
Normal-vs-Grade 2
8.735400E-01
Normal-vs-Grade 3
8.327400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.106800E-01
Grade 1-vs-Grade 3
2.083800E-01
Grade 1-vs-Grade 4
9.276400E-01
Grade 2-vs-Grade 3
4.377800E-01
Grade 2-vs-Grade 4
8.735400E-01
Grade 3-vs-Grade 4
8.327400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.749200E-01
Normal-vs-NonDiabetic
7.521000E-01
Diabetic-vs-NonDiabetic
3.804600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.497200E-01
Normal-vs-NoPancreatitis
7.741600E-01
Pancreatitis-vs-NoPancreatitis
1.640770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.753600E-01
Normal-vs-N1
8.758600E-01
N0-vs-N1
2.025800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.657400E-01
Normal-vs-TP53-NonMutant
8.344400E-01
TP53-Mutant-vs-TP53-NonMutant
2.065800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
